Mellgren R L, Lane R D, Kakar S S
Department of Pharmacology and Therapeutics, Medical College of Ohio, Toledo 43699.
Biochim Biophys Acta. 1987 Oct 1;930(3):370-7. doi: 10.1016/0167-4889(87)90010-3.
Purified bovine myocardial sarcolemma vesicles were shown to contain calcium-dependent proteinase inhibitor protein by direct assay and by immunoblot analysis following gel electrophoresis (Western blotting). Calcium-dependent proteinase (calpain, EC 3.4.22.17) was not detected in the sarcolemma vesicles. The inhibitor protein was not solubilized when the vesicles were ruptured by repetitive freezing and thawing. However, a large amount of latent inhibitor activity was exposed after freezing and thawing the sarcolemma, and the inhibitor was much more susceptible to removal by 1.0 M NaCl or proteolysis following this treatment. Since the vesicles were predominantly right-side-out, the latter observations suggested that the inhibitor was associated with the cytoplasmic face of the sarcolemma. The endogenous inhibitor was capable of protecting sarcolemmal protein kinase C from proteolytic conversion to soluble protein kinase M by type I or type II calcium-dependent proteinase. Thus, the inhibitor is probably important in controlling calcium-dependent proteolysis of sarcolemmal proteins.
通过直接测定以及凝胶电泳(蛋白质免疫印迹法)后的免疫印迹分析表明,纯化的牛心肌肌膜囊泡含有钙依赖性蛋白酶抑制蛋白。在肌膜囊泡中未检测到钙依赖性蛋白酶(钙蛋白酶,EC 3.4.22.17)。当囊泡通过反复冻融破裂时,抑制蛋白未被溶解。然而,肌膜冻融后大量潜在的抑制活性被暴露出来,并且经过这种处理后,该抑制剂更容易被1.0 M NaCl去除或被蛋白酶水解。由于囊泡主要是外翻的,后一观察结果表明该抑制剂与肌膜的细胞质面相关。内源性抑制剂能够保护肌膜蛋白激酶C不被I型或II型钙依赖性蛋白酶蛋白水解转化为可溶性蛋白激酶M。因此,该抑制剂可能在控制肌膜蛋白的钙依赖性蛋白水解中起重要作用。